Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients

Bruno Fautrel (1) , Manon Belhassen (2) , Christophe Hudry , Marie-Christine Woronoff-Lemsi (3, 4) , Laurie Levy-Bachelot , Eric van Ganse (2) , Florence Tubach (1, 5)

1 CHU Pitié-Salpêtrière [AP-HP]
2 HESPER - Health Service and Performance Research
3 CHRU Besançon - Centre Hospitalier Régional Universitaire de Besançon
4 RIGHT - Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098)
5 CIC Paris-Est - Centre d'investigation clinique Paris Est [CHU Pitié Salpêtrière]

Domaines: Sciences du Vivant [q-bio]

Bruno Fautrel, Manon Belhassen, Christophe Hudry, Marie-Christine Woronoff-Lemsi, Laurie Levy-Bachelot, et al.. Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients. Joint Bone Spine, 2020, 87, pp.137 - 139. ⟨10.1016/j.jbspin.2019.10.004⟩. ⟨hal-03489955⟩